Faculty and Staff


Stephanie Yanow, PhD


Public Health, School of | Medicine & Dentistry

Medical Microbiology and Immunology

About Me

Education and Training

PhD in Cell Biology 1998 – 2001
Imperial Cancer Research Fund,
University College London, 
London, England

Bachelor of Science, First Class Honours 1992 – 1996
Department of Biology, 
McGill University, 
Montreal, Quebec, Canada

Postdoc training: McGill University (2004-2006), California Institute of Technology (2001-2003)


  • 1998 – 2001 Overseas Research Studentship award, University College London
  • 1998 – 1999 British Council Chevening/Athlone-Vanier Fellowship
  • 1998 – 2000 Natural Sciences and Engineering Research Council of Canada post-graduate award
  • 2000 Promega UK Young Life Scientist of the Year
  • 2001 – 2003 Caltech Divisional Fellowship
  • 2004 – 2007 Fonds de Recherche en Santé du Québec Postdoctoral Fellowship; declined
  • 2004 – 2006 Richard H. Tomlinson postdoctoral fellowship, McGill University
  • 2004 – 2007 CIHR postdoctoral fellowship
  • 2011 Rising Stars in Global Health Award, Grand Challenges Canada
  • 2014 – 2016 Host, Visiting Scientist Award from Alberta Innovates – Health Solutions
  • 2014 Endeavour Executive Fellowship, Australia


Research collaborations within the University of Alberta:

  • Department of Biological Sciences, Canada
  • Department of Medical Microbiology & Immunology, Canada

Research collaborations with other academic institutions:

  • Griffith University, Australia
  • University of Antioquia, Colombia
  • FIOCRUZ, Brazil
  • NIRTH, India
  • University of Toronto, Canada
  • University of Copenhagen, Denmark
  • University of South Florida, USA

Collaborations with governmental organizations:

  • Ministry of Health, Uganda

Collaborations with industry:

  • Aquila Diagnostic Systems Inc., Canada


My research program is focused on different aspects of malaria from basic pathogenesis to translational development of diagnostics and vaccines. My lab is engaged in a multidisciplinary collaboration to transfer molecular diagnostic tests for malaria to a platform to be used at the point-of-care in limited-resource areas. We have partnered with international colleagues to pilot this technology in malaria-endemic settings (Uganda, India). Another major focus of our work is on the interactions between malaria parasites of different species and the host immune response, particularly during infection in pregnancy. From our work with colleagues in Colombia and Brazil, we discovered that exposure to Plasmodium vivax may induce protective antibodies against P. falciparum in pregnancy, leading to improved birth outcomes. My team is now trying to understand this mechanism of cross-species immunity and exploit these findings for vaccine development.